menu
    • menu

    Company profile for PreludeDx

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PreludeDx was founded with the goal of providing better decision-making tools to breast cancer patients and physicians. Founded in 2009 with technology licensed from University of California San Francisco, PreludeDx has focused on developing breast cancer tools that will impact a patient’s treatment decision. Our mission is to provide tools that improve patient outcomes in breast cancer and reduce the overall cost burden to ...
    PreludeDx was founded with the goal of providing better decision-making tools to breast cancer patients and physicians. Founded in 2009 with technology licensed from University of California San Francisco, PreludeDx has focused on developing breast cancer tools that will impact a patient’s treatment decision. Our mission is to provide tools that improve patient outcomes in breast cancer and reduce the overall cost burden to the healthcare system PreludeDx will strive to find new innovative tools and processes that assist patients and physicians for the better management of cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PreludeDxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    26051 Merit Cir #103 Laguna Hills, CA 92653
    Telephone
    Telephone
    888.211.3247
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://preludedx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/preludedx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/PreludeDx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Preludedx Appoints Mimi Reyes To Senior Management Team
    Preludedx Appoints Mimi Reyes To Senior Management Team

    22 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/preludedx-appoints-mimi-reyes-as-senior-executive-management-team-to-support-growth-initiatives-302667369.html

    PR NEWSWIRE
    22 Jan 2026
    Share Share
    PreludeDx Study Shows DCISionRT in DCIS Treatment Management
    PreludeDx Study Shows DCISionRT in DCIS Treatment Management

    31 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/preludedx-study-demonstrates-superiority-of-dcisionrt-over-clinicopathology-factors-and-criteria-for-dcis-treatment-management-302518339.html

    PR NEWSWIRE
    31 Jul 2025
    Share Share
    PreludeDx to Present Data on Utility of DCISionRT in Patients with DCIS
    PreludeDx to Present Data on Utility of DCISionRT in Patients with DCIS

    05 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/12/05/2790758/0/en/PreludeDx-to-Present-New-Data-on-the-Clinical-Utility-of-DCISionRT-in-Australian-Patients-with-DCIS-at-the-2023-San-Antonio-Breast-Cancer-Symposium.html

    GLOBENEWSWIRE
    05 Dec 2023
    Share Share
    PreludeDx to Present Data for Biosignature to Predict Radiation Therapy Benefit
    PreludeDx to Present Data for Biosignature to Predict Radiation Therapy Benefit

    29 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/29/2787608/0/en/PreludeDx-to-Present-Data-for-a-Novel-Molecular-Biosignature-to-Predict-Radiation-Therapy-Benefit-in-Early-Stage-Invasive-Breast-Cancer-at-the-2023-San-Antonio-Breast-Cancer-Sympos.html

    GLOBENEWSWIRE
    29 Nov 2023
    Share Share
    PreludeDx to Present Multiple Presentations at the 2023 San Antonio Symposium
    PreludeDx to Present Multiple Presentations at the 2023 San Antonio Symposium

    16 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/16/2781737/0/en/PreludeDx-to-Present-Multiple-Presentations-at-the-2023-San-Antonio-Breast-Cancer-Symposium.html

    GLOBENEWSWIRE
    16 Nov 2023
    Share Share
    PreludeDx Presents Risk Assessments for DCIS Patients Using RTOG 9804
    PreludeDx Presents Risk Assessments for DCIS Patients Using RTOG 9804

    02 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/02/2752907/0/en/UPDATE-PreludeDx-Presents-Risk-Assessments-for-DCIS-Patients-Using-Clinicopathologic-Based-Models-Like-RTOG-9804-and-MSKCC-Compared-to-DCISionRT.html

    GLOBENEWSWIRE
    02 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search